51. Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid
- Author
-
Shalini Shukla, Sonali Rudra, Tarun Mathur, A.V.S. Raja Rao, A.S.S.V. Srinivas, Manisha Pandya, Sunita Malhotra, Pragya Bhateja, Anita Mehta, Ajay Singh Yadav, Ashok Rattan, Biswajit Das, Suman Saini, S. K. Arora, Ajay Soni, and Abhijit Ray
- Subjects
Stereochemistry ,Clinical Biochemistry ,Pharmaceutical Science ,Microbial Sensitivity Tests ,Gram-Positive Bacteria ,Biochemistry ,Chemical synthesis ,chemistry.chemical_compound ,Mice ,Structure-Activity Relationship ,Heterocyclic Compounds ,Drug Discovery ,Eperezolid ,Structure–activity relationship ,Animals ,Furans ,Molecular Biology ,Oxazoles ,Oxazolidinones ,Antibacterial agent ,Chemistry ,Organic Chemistry ,Drug Resistance, Microbial ,Staphylococcal Infections ,Ranbezolid ,Anti-Bacterial Agents ,Piperazine ,Molecular Medicine - Abstract
Novel oxazolidinones were synthesized containing a number of substituted five-membered heterocycles attached to the 'piperazinyl-phenyl-oxazolidinone' core of eperezolid. Further, the piperazine ring of the core was replaced by other diamino-heterocycles. These modifications led to several compounds with potent activity against a spectrum of resistant and susceptible gram-positive organisms, along with the identification of ranbezolid (RBx 7644) as a clinical candidate.
- Published
- 2005